Technical Data
T9160-20A
Tumor Necrosis Factor alpha, Recombinant, Rat (TNFa)
10ug
Molecular Biology Storage: -70CShipping: RT
Tumor Necrosis Factor alpha (TNF-alpha) is a 17.3kD multi-functional pro-inflammatory cytokine primarily secreted by macrophages, but also produced by T and B lymphocytes, activated monocytes and fibroblasts. TNF-alpha exists in both a transmembrane and mature soluble form and has many biological properties, including activation of transcription factor NF-KappaB, the induction of apoptosis in various tumor cell lines and the stimulation of cell differentiation and proliferation under certain conditions. Studies have revealed a role for TNF-alpha in inflammation, septic shock, autoimmune disease and rheumatoid arthritis.

Source:
Recombinant corresponding to rat Tumor Necrosis Factor alpha expressed in E. coli.

Endotoxin: ~0.1ng/ug

Biological Activity:
ED50 range =0.005-0.02ng/ml, determined by the dose dependent cytolysis of mouse L-929 cells in the presence of actinomycin D. Optimal concentration for individual application should be determined by a dose response assay.

Storage and Stability:
Lyophilized powder may be stored at 4C for short-term only. Reconstitute to nominal volume by adding sterile dH2O and store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Molecular Weight:
17kD
Source: E. coli
Purity: ~95% (SDS-PAGE). Purified by sequential chromotography.
Concentration: ~0.1-1mg/ml
Form: Supplied as a lyophilized powder. BSA free. Reconstitute with sterile dH2O to 0.1-1mg/ml.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
1. Albina, J.E., et al., Am. J. Physiol.-Cell Physiology 281(6): C1971-C1977 (2001). 2. Balchak, S.K., et al., Reproductive Toxicology 14: 533-539 (2000). 3. Bhalla, D.K., et al., Toxicol. Sci. 69(2): 400-408 (2002). 4. Davis, J.R., et al., Am. J. Physiol.-Regulatory Integrative and Comparative Physiology 282(2): R390-R399 (2002). 5. Fang, L., et al., Am. J. Physiol.-Regulatory Integrative and Comparative Physiology 280(5): R1356-R1363 (2001). 6. Hou, S.H., et al., J. Virol. 76(7): 3212-3220 (2002). 7. Krown, K.A., et al., J. Clin. Invest. 98(12): 2854-2865 (1996). 8. Lee, S.J., et al., J. Immunol. 165: 4658-4666 (2000). 9. Lee, S.J., et al., J. Immunol. 164: 1277-1285 (2000). 10. Loparev, V., et al., Proc. Natl. Acad. Sci. 95(7): 3786-3791 (1998). 11. McTiernan, C.F., et al., Circ. Research 81: 493-503 (1997). 12. Miagkov, A., et al., Proc. Natl. Acad. Sci. 95(23): 13,859 (1998). 13. Roos, A., et al., J. Leukocyte Biol. 64: 503-510 (1998). 14. Tsai, S.-Y., et al., Cell Tissue Res. 303: 423-431 (2001). 15. Yang, S.Q., et al., Proc. Natl. Acad. Sci. 94: 2557-2562 (1997).

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.